IART vs ZION · rev $1.64B vs P/E 11, rev $354.0M
Integra LifeSciences Holdings (IART) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported IART revenue for 2025-12-31 was $1.64B. Net income was -$516.5M. IART currently screens at market cap $1.32B.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
IART currently screens at market cap $1.32B. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the IART and ZION stock pages for the full models.
Not investment advice.